The draft programme of the annual TBVI meeting, will be held in Les Diablerets, Switzerland from 18 – 20 January 2022 is available here.
New TB vaccines are on the horizon, but their success is not guaranteed. World leaders pledged to deliver at least USD $2 billion annually for TB research, including vaccines, at the 2018 United [...]
The STriTuVaD Consortium announces the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for TB
The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB). Please read the press release